Ben Price

Ben Gil Price is currently an Independent Non-Executive Director at Percheron Therapeutics Ltd., a Director at AssayQuant Technologies, Inc., and the Chief Medical Officer at KCBN Holding, Inc. He previously worked as a Clinical Development Director-Oncology at MedImmune LLC from 1997 to 2002, an Independent Director at Sarepta Therapeutics, Inc. from 2007 to 2016, a Director at Rexahn Pharmaceuticals, Inc. from 2018 to 2020, and as the Chief Executive & Medical Officer at Drug Safety Solutions LLC from 2002 to 2017.
He is also a Member of the American Medical Association, the Academy of Physicians In Clinical Research, and the American Society for Microbiology.
Dr. Price holds an undergraduate degree from the University of Rio Grande and graduate and doctorate degrees from the University of Santiago de Compostela.